Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung.

Susan L. Tucker,Zhong Xing Liao,Elizabeth L. Travis

DOI: https://doi.org/10.1016/S0360-3016(97)00131-4

1997-07-15

Abstract:

What problem does this paper attempt to address?

Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study

Adrian Jochim-Vukosavic,Frank Schwab,Leonard Knegendorf,Dirk Schlüter,Franz-Christoph Bange,Ella Ebadi,Claas Baier

DOI: https://doi.org/10.1371/journal.pone.0297866

IF: 3.7

2024-02-27

PLoS ONE

Abstract:Vancomycin-resistant enterococci (VRE) occur in hospitalized patients, causing both infection and colonization. In recent years, there has been an increase in VRE in German and other hospitals, raising the question of how to control this epidemic best. To better understand the specific epidemiology and to guide infection control, we conducted a retrospective cohort study analyzing all patients with VRE at Hannover Medical School, a tertiary university clinic in Germany that specializes in solid organ transplantation. Epidemiologic and clinical characteristics of patients with VRE from 2015–2017 were collected. Basic epidemiologic parameters, including VRE incidence and incidence density, were calculated. Independent risk factors for nosocomial VRE infection compared to colonization were assessed using a logistic regression model. There were 1,492 VRE cases corresponding to 822 individual patients. The incidence was 0.8 VRE cases per 100 cases. A total of 536 (35.9%) of the 1,492 VRE cases were acquired nosocomially. Of the 1,492 cases, 912 cases had VRE-positive samples (894 Enterococcus ( E .) faecium and 18 E . faecalis ) in our hospital laboratory and the remaining cases were known VRE carriers. The vanB -phenotype was observed in 369 of the 894 (41.3%) E . faecium isolates and in 6 of the 18 (33.3%) E . faecalis isolates. There was an increase over time in the vanB -phenotype proportion in E . faecium (2015: 63 of 171, 36.8%, 2016: 115 of 322, 35.7% and 2017: 191 of 401, 47.6%). A total of 107 cases had a VRE infection (7.2% of all VRE cases) according to the criteria of the German National Reference Center for Surveillance of Nosocomial Infections. The remaining cases were only colonized. Among other factors, leukocytopenia (<1,000/μL), the use of a central venous catheter and the visceral surgery medical specialty were independently associated with nosocomial VRE infection. VRE imposed a relevant and increasing infection control burden at our hospital. Nosocomial VRE infection was predominantly found in certain medical specialties, such as hematology and oncology and visceral surgery. Infection control efforts should focus on these highly affected patient groups/specialties.

multidisciplinary sciences
Multicenter Clinical Investigation of Vancomycin-resistant Enterococcus Infection

Dongfang Lin,Yan Guo,Yang Yang,Shi Wu,Yonggui Zheng,Demei Zhu,Fupin Hu

DOI: https://doi.org/10.21203/rs.3.rs-110647/v1

2020-01-01

Abstract:Abstract Background: To understand the clinical characteristics of vancomycin-resistant Enterococcus (VRE) infection.Methods: The clinical characteristics of patients with VRE infection, members of CHINET Bacterial Drug Resistance Monitoring Network, in 2016, were analyzed and compared to patients with vancomycin-susceptible Enterococcus (VSE) infection patients.Results: Urinary tract infection was the main type, followed by bloodstream infection and intraabdominal infection. Compared to VSE infection, VRE infection is observed in more patients who have intravenous catheterization and undergo dialysis. In addition, the proportion of patients complicated with shock, multiple organ failure, and other bacterial and fungal infections is high, the clinical outcome is poor, the hospitalization expenses are high, and the hospitalization duration is prolonged. Multivariate logistic regression analysis showed that intravenous catheterization was an independent risk factor for VRE infection.Conclusions: Intravenous catheterization is an independent risk factor for VRE infection. Thus, clinical measures should be strengthened to prevent VRE infection.
A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient

Myeongji Kim,Christopher Graham,Ryan W Stevens,Aditya Shah

DOI: https://doi.org/10.1155/2024/2193650

2024-07-25

Abstract:Vancomycin-resistant Enterococcus faecium (VRE) meningitis is rare. It is usually associated with neurosurgical procedures or devices. We describe a case of VRE meningitis from hematogenous spread during persistent bacteremia in an immunocompromised patient who received haploidentical bone marrow transplant for VEXAS syndrome. The bacteremia and meningitis were successfully treated with combination of intravenous (IV) daptomycin, ceftaroline, and linezolid.
576. A Multicenter Epidemiology Study on Risk Factors of Vancomycin-Resistant Enterococcus Infections in China: Results from the China Antimicrobial Surveillance Network (CHINET) in 2016

Dongfang Lin,Yan Guo,Yang Yang,Demei Zhu,Fupin Hu

DOI: https://doi.org/10.1093/ofid/ofz360.645

2019-01-01

Open Forum Infectious Diseases

Abstract:Abstract Background Bacterial resistance in China had been increasing in prevalence. Vancomycin-resistant enterococcus (VRE) different from other bacteria had lower isolated rate and apparent regional variations. In this study, we identified the characteristics of VRE infections in Chinese patients based on the China Antimicrobial Surveillance Network (CHINET) in 2016. Methods This case–control study was conducted in 97 VRE patients and 95 Vancomycin-susceptible Enterococcus (VSE) patients from 20 medical centers. Demographics, disease characteristics, therapeutic measure, as well as laboratory data were obtained from medical records for analysis. Descriptive statistics, simple and multivariate logistic regression were performed to explore the risk factors of VRE infection. Results The mean age of patients in the case and control groups was 75.0 years and 65.0 years, respectively. In the case group, 52 patients developed urinary tract infections, accounting for 53.6%, followed by bloodstream infections (19.6%) and abdominal infections (5.2%). And the cases of Enterococcus faecium, Enterococcus faecalis and other enterococci infections were 70 (72.2%), 7 (7.2%), and 20 (20.6%), respectively. Moreover, the proportion of vancomycin usage before infection was 20.6%. The result of resistance analysis showed VRE patients’ other dug resistance rate was higher than VSE ones. Compared with VSE patients, VRE patients had received more urinary intubation, indwelling venous catheter, and dialysis. Additionally, the proportions of combination with stroke (8.3% vs. 2.1%), multiple organ failure (8.3% vs. 3.2%), and other infection (59.8% vs. 40.0%) were higher in the case group. What’s more, 44 (45.4%) VRE patients had been treated in intensive care unit, while 21 (22.1%) cases in the control group. Multivariate logistic regression showed that receiving indwelling venous catheter was independent risk factor for VRE infection (OR=3.342, 95% CI: 1.379~8.099). For prognosis, VRE patients had a lower effective rate (67.4% vs. 83.7%), higher hospital expense (￥94991 vs. ￥38248), and longer hospital stay (26.0 days vs. 21.0 days). Conclusion Indwelling venous catheter may increase the VRE infection risk and Linezolid or Fosfomycin could still be used for infection treatment in VRE patients. Disclosures All authors: No reported disclosures.
Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

Kyo Jin Jo,Hyeon Seo Lee,Narae Lee,Shin Yun Byun,Chulhun Chang,Su Eun Park

DOI: https://doi.org/10.1016/j.pedneo.2024.01.007

2024-06-13

Abstract:Background: We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children. Methods: We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021. Results: In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%. Conclusion: Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
Exploring the design of an intentional naming scheme with an automatic constraint analyzer

S. Khurshid,D. Jackson

DOI: https://doi.org/10.1109/ASE.2000.873646

2000-09-11

Abstract:Lightweight formal modeling and automatic analysis were used to explore the design of the intentional naming system (INS), a new scheme for resource discovery in a dynamic networked environment. We constructed a model of INS in Alloy a lightweight relational notation, and analyzed it with the Alloy Constraint Analyzer, a fully automatic simulation and checking tool. In doing so, we exposed several serious flaws in both the algorithm of INS and the underlying naming semantics. We were able to characterize the conditions under which the existing INS scheme works correctly, and evaluate proposed fixes.
Characterization of Clinical Enterococci Isolates, Focusing on the Vancomycin-Resistant Enterococci in a Tertiary Hospital in China: Based on the Data from 2013 to 2018

Wanqing Zhou,Hui Zhou,Yuhan Sun,Shuo Gao,Yan Zhang,Xiaoli Cao,Zhifeng Zhang,Han Shen,Chunni Zhang

DOI: https://doi.org/10.1186/s12879-020-05078-4

IF: 3.7

2020-01-01

BMC Infectious Diseases

Abstract:Background Vancomycin-resistant Enterococcus spp. (VRE) have spread all over the world. The present study aims to investigate the species distribution, specimen type and susceptibilities of Enterococcal species collected from Nanjing Drum Tower Hospital from 2013 to 2018. Additionally, distribution of VRE and prevalence of van gene among VRE isolates were also analyzed. Methods The susceptibilities of 3913 Enterococcus isolates were retrospectively investigated. Among these strains, 60 VRE strains were further anazlyed in this study. The minimum inhibitory concentrations (MICs) of the VRE strains towards vancomycin, teicoplanin and linezolid were determined by E-test. Polymerase chain reaction (PCR) and DNA sequencing were used to investigate the prevalence of van genes among VRE. Furthermore, the sequence types (STs) of VRE strains were explored by multi-locus sequence typing (MLST). Results Among the 3913 enterococci isolates, Enterococcus faecalis ( n = 1870, 47.8%) and Enterococcus faecium (1738, 44.4%) were the main isolates. These Enterococcus strains were mainly isolated from urine ( n = 1673, 42.8%), followed by secretions ( n = 583, 14.9%) and ascites ( n = 554, 14.2%). VRE displayed a decreasing trend year by year. Molecular analysis revealed that 49 out of 60 VRE isolates carried vanA gene, 10 carried vanM , and 1 carried both vanA and vanM genes. Sixteen distinct STs were identified among the 58 VREM, with ST78 ( n = 16), ST192 ( n = 8) and ST570 ( n = 7) being the most dominant ones. Conclusions E. faecalis and E. faecium were the major enterococci strains which are the main pathogens of urinary traction infections; vanA and vanM were the main determinants conferring resistance to vancomycin; ST78, ST192 and ST570 were the leading STs of VREM which displayed a decreasing trend of prevalence year by year.
Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients

Murat Sutcu,Hacer Akturk,Manolya Acar,Nuran Salman,Derya Aydın,Bahar Akgun Karapınar,Aslı Ozdemir,Rukiye Cihan,Agop Citak,Ayper Somer

DOI: https://doi.org/10.1016/j.ajic.2015.11.026

2016-05-01

Abstract:Background: We aimed to determine the frequency of vancomycin-resistant enterococci (VRE) infection occurrence in previously VRE-colonized children in a pediatric intensive care unit (PICU) and to identify associated risk factors. Methods: Infection control nurses have performed prospective surveillance of health care-associated infections and rectal VRE carriage in PICUs from January 2010-December 2014. This database was reviewed to obtain information about VRE-colonized and subsequently infected patients. A case-control study was performed to identify risk factors associated with VRE infection development in previously VRE-colonized patients. Results: Out of 1,134 patients admitted to the PICU, 108 (9.5%) were found to be colonized with VRE throughout the study period. Systemic VRE infections developed in 11 VRE-colonized patients (10.2%), and these included primary bloodstream infection (n = 6), urinary tract infection (n = 3), meningitis and bloodstream infection (n = 1), and meningitis (n = 1). Logistic regression analysis indicated long hospital stay (≥30 days) and glycopeptide use after detection of VRE colonization as risk factors for developing VRE infection in VRE-colonized patients (odds ratio [OR], 5.76; 95% confidence interval [CI], 1.6-15.8; P = .017 and OR, 12.8; 95% CI, 1.9-26.6; P = .012, respectively). Conclusions: VRE colonization has important consequences in pediatric critically ill patients. Strict infection control measures should be implemented to prevent VRE colonization and thereby VRE infections. Furthermore, irrational antibiotic use and particularly glycopeptide use in VRE-colonized patients should be restricted.
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium

Emma G Mills,Alexander B Smith,Marissa P Griffith,Katharine Hewlett,Lora Pless,Alexander J Sundermann,Lee H Harrison,Joseph P Zackular,Daria Van Tyne

DOI: https://doi.org/10.1101/2024.08.01.24311290

2024-08-03

Abstract:Vancomycin-resistant Enterococcus faecium (VREfm) is a prevalent healthcare-acquired pathogen. Gastrointestinal colonization can lead to difficult-to-treat bloodstream infections with high mortality rates. Prior studies have investigated VREfm population structure within healthcare centers. However, little is known about how and why hospital-adapted VREfm populations change over time. We sequenced 710 healthcare-associated VREfm clinical isolates from 2017-2022 from a large tertiary care center as part of the Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT) program. Although the VREfm population in our center was polyclonal, 46% of isolates formed genetically related clusters, suggesting a high transmission rate. We compared our collection to 15,631 publicly available VREfm genomes spanning 20 years. Our findings describe a drastic shift in lineage replacement within nosocomial VREfm populations at both the local and global level. Functional and genomic analysis revealed, antimicrobial peptide, bacteriocin T8 may be a driving feature of strain emergence and persistence in the hospital setting.

Infectious Diseases (except HIV/AIDS)
Prevalence, Microbial Etiology and Risk Factors Associated With Healthcare Associated Infections Among End Stage Renal Disease Patients on Renal Replacement Therapy

Saad Hanif Abbasi,Raja Ahsan Aftab,Pauline Siew Mei Lai,Soo Kun Lim,Ruwaida Nur Zainol Abidin

DOI: https://doi.org/10.1177/08971900221094269

2022-04-24

Journal of Pharmacy Practice

Abstract:End stage renal disease (ESRD) patients on renal replacement therapy (RRT) have an increased risk of morbidity and mortality due to healthcare associated infections (HCAIs). The aim of this study is to determine the prevalence, microbial etiology, and risk factors associated with HCAIs among ESRD patients on RRT. A multicenter, retrospective study was conducted from June to December 2019. ESRD patients with minimum of 6 months on RRT were included, while pregnant patients and patients <18 years were excluded. To reduce the risk of selection bias, all patients were randomly selected using a simple random sampling technique. The prevalence showing the proportion of patients that acquired HCAI since the initiation of dialysis until 2019 was calculated using the European patients’ academy (EUPATI) formula. Risk factors were assessed using univariate and multivariate regression analysis. The prevalence of HCAI among ESRD patients was 174/400 (43.5%). Catheter related bloodstream infection (CRBSI) was the most common infection [64(36.8%)], followed by peritonitis [45(25.8%)] and pneumonia [37(21.2%)]. Out of 382 total pathogens identified, 204 (53.4%) were Gram positive and 162 (42.4%) were Gram negative. Both methicillin sensitive staphylococcus aureus (MSSA) and methicillin resistant staphylococcus aureus (MRSA) showed statistically significant associations (p<0.05) with CRBSI. Use of multiple accesses, increased blood sugar levels, low serum sodium levels and higher CRP concentration increased the occurrence of HCAIs. The burden of HCAIs among the patients undergoing RRT is high. Preventive strategies and optimum empirical therapy of antibiotics should be used to reduce the risk of these infections among ESRD patients.
The evaluation of vancomycin-resistant enterococci and carbapenamase producing Klebsiella colonization among ICU-Hospitalized Patients

Gökhan Karaşin,Yasemin Bayram,Mehmet Parlak,Cenk Aypak,Mustafa Akgül,Hüseyin Güdücüoğlu

DOI: https://doi.org/10.4314/ahs.v21i4.20

Abstract:Background: Multi-drug resistant organisms, especially Vancomycin-Resistant Enterococcus (VRE) and Carbapenam Resistant Klebsiella pneumoniae (KPC), are serious health threat. Early detection of resistant bacteria colonization among patients in intensive care units (ICUs) not only enables effective treatment but more importantly prevents disease and limits transmission. Therefore, we aimed to to assess the frequency of VRE and KPC colonization via rectal swab sampling. Methods: The study was carried out in ICUs of a tertiary hospital. Two rectal swab samples were collected within the first 24 hours of admission and another one was taken every subsequent 15 days to test for for VRE and KPC carriage. Results: A total 316 rectal swab samples taken from 230 patients. Forty-seven patients were screened at least 2 times. 183 patients were not further screened due to discharge, exitus or transfer to other wards. Thirty-six patients (16%) were determined to be VRE (+). The most frequently isolated strain was E. faecium (80.5%) and its most common genotype was VanA (87.5%). Seven patients (3%) were identified as KPC (+). OXA-48 type crbapenamase was confirmed in all KPC isolates. Conclusion: This study shows that VRE and KPC colonization continues to be a serious threat in ICUs.
Intraperitoneal vancomycin treatment of multifocal methicillin-resistant Staphylococcus aureus osteomyelitis in a patient on peritoneal dialysis

Qassim Abid,Basim Asmar,Edward Kim,Leah Molloy,Melissa Gregory,Rudolph P Valentini

DOI: https://doi.org/10.1093/ajhp/zxaa244

2020-10-14

Abstract:Purpose: We report the case of a 2-year-old girl with end-stage renal disease managed by peritoneal dialysis (PD) who developed methicillin-resistant staphylococcal osteomyelitis of the left shoulder and was successfully treated with intraperitoneal (IP) administration of vancomycin for 2 weeks followed by oral clindamycin therapy. Summary: The patient was hospitalized with tactile fever and a 3-day history of worsening fussiness. Radiography of the left shoulder showed findings indicative of osteomyelitis. Vancomycin was administered via central venous line for 3 days, during which time the patient underwent PD 24 hours a day. After magnetic resonance imaging revealed proximal humeral osteomyelitis, septic arthritis of the shoulder joint, and osteomyelitis of the scapula, the patient underwent incision and drainage of the left shoulder joint. Both blood and joint drainage cultures grew methicillin-resistant Staphylococcus aureus that was sensitive to vancomycin. The patient's central venous catheter was removed on hospital day 4; due to difficulties with peripheral i.v. access and a desire to avoid placing a peripherally inserted central venous catheter, vancomycin administration was changed to the IP route, with vancomycin added to the PD fluid. During IP treatment, serum vancomycin levels were maintained at 13.5 to 18.5 mg/L, and the calculated ratio of vancomycin area under the curve to minimum inhibitory concentration was maintained above 400. After completing a 14-day course of IP vancomycin therapy, the patient was switched to oral clindamycin, with subsequent complete resolution of osteomyelitis. Conclusion: IP vancomycin was effective for treatment of invasive S. aureus infection in this case. This approach should be considered in patients undergoing PD for whom peripheral i.v. access options are limited and/or not preferred.
Prevalence and Resistance Profiles of Pediatric Enterococcal Isolates: A Five-Year Update from Children's Medical Center Hospital, Tehran

Bahram Nikmanesh,Sajjad Yazdansetad,Mona Konkori,Mehrzad Sadredinamin,Zohreh Ghalavand,Neda Yousefi Nojookambari

DOI: https://doi.org/10.1155/2024/5529598

2024-07-30

Abstract:Background: In this study, attempts were made to evaluate the frequency of high-level gentamicin-resistant (HLGR) and vancomycin-resistant enterococci (VRE) and the prevalence and antibiotic resistance profile of enterococcal species isolated from pediatric patients referred to Children's Medical Center Hospital, Tehran, over five years. Materials and methods: A total of 404 enterococcal isolates from different patients referred to the Children's Medical Center between March 2016 and March 2021 were included in this cross-sectional study. Antimicrobial susceptibility testing was performed using standard methods according to the guidelines of the Clinical Laboratories Standards Institute (CLSI). Results: Approximately one-third of the enterococcal strains were isolated from urology and intensive care units. 17.3% of the isolates were obtained from outpatient sources. However, 82.7% of the isolates were sourced from inpatient settings. We found that the rates of resistance to ampicillin, penicillin, and vancomycin were twice as high in inpatients as in outpatients. Of the total isolates, 87.4% and 49.3% were identified as HLGR and VRE, respectively. In addition, we identified 2% of the VRE isolates that were not susceptible to linezolid. Nitrofurantoin showed excellent activity against enterococcal isolates in the urine, with a susceptibility rate of 92.5%. Conclusion: The present study reports the highest range of VRE isolated from pediatric patients in Iran. Despite the predominance of HLGR enterococci in our region, vancomycin remains effective against such strains. This study is among the few to demonstrate the incidence of linezolid-insensitive VRE in pediatric patients. Therefore, it is important to evaluate effective infection control measures to prevent linezolid and vancomycin resistance in enterococci.
Infective Endocarditis in Patients with End-Stage Renal Disease on Dialysis: Epidemiology, Risk Factors, Diagnostic Challenges, and Management Approaches

Rochell Issa,Nourhan Chaaban,Abdullah Salahie,Bianca Honnekeri,Gary Parizher,Bo Xu

DOI: https://doi.org/10.3390/healthcare12161631

2024-08-18

Health Care

Abstract:Infective endocarditis (IE) poses a significant clinical challenge, especially among patients with end-stage renal disease (ESRD) undergoing dialysis, and is associated with high morbidity and mortality rates. This review provides a contemporary discussion of the epidemiology, risk factors, diagnostic challenges, and management strategies for IE among ESRD patients, including a literature review of recent studies focused on this vulnerable population. The review highlights the multifactorial nature of IE risk in ESRD patients, emphasizing the roles of vascular access type, dialysis modality, and comorbid conditions. It also explores the diagnostic utility of different imaging modalities and the importance of a multidisciplinary approach in managing IE, including both medical and surgical interventions. The insights from this review aim to contribute to the improvement of patient outcomes through early recognition, appropriate antimicrobial therapy, and timely surgical intervention when necessary.

health care sciences & services,health policy & services
A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China

Sha Liu,Yan Li,Ziqiang He,Yan Wang,Jing Wang,Dong Jin

DOI: https://doi.org/10.1016/j.jgar.2022.10.010

IF: 4.349

2022-12-01

Journal of Global Antimicrobial Resistance

Abstract:OBJECTIVES: Vancomycin-resistant enterococci (VRE) are one of the most important bacterial causes of healthcare-associated infections (HAIs). In China, the detection rate of VRE Enterococcus faecium (VREfm) is low, although VREfm had a high prevalence in our hospitals between 2013-2015. In this study, we used molecular typing methods combined with epidemiological data to investigate the spread of VREfm in our hospital.METHODS: The characteristics of E. faecium strains isolated from 89 patients with HAIs, including antibiotic susceptibility and virulence genes, were analyzed. This study analyzed 50 E. faecium strains isolated from 47 intensive care unit and Emergency ward patients using core genome Multilocus Sequence Typing and transposon typing. Epidemiological information about those patients was also analyzed.RESULTS: Twenty-seven E. faecium isolates containing the vanA gene were identified as VREfm in 89 non-duplicate E. faecium isolates. The major clonal VREfm strains that persisted from 2013-2015 were CT1/ST78/PFGE cluster A that contained transposon type Ⅰ. The other CT4/ST363/PFGE cluster of VREfm strains also contained transposon type Ⅰ. Three patients acquired different clonal E. faecium strains during the hospital period, and the VREfm strain infected one patient.CONCLUSIONS: In this study, we report the spread caused by vanA vancomycin-resistant E. faecium strains of different cluster types with the same type of transposon in a tertiary hospital. Our literature review revealed that this is the first report of the HAIs caused by ST363/CT4 VREfm strains.

pharmacology & pharmacy,infectious diseases
Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line

Weiran Chen,R. Mi,N. Haughey,M. Oz,A. Höke

DOI: https://doi.org/10.1111/j.1529-8027.2007.00131.x

IF: 5.188

2007-06-01

Journal of the Peripheral Nervous System

Abstract:Abstract Development of neuroprotective strategies for peripheral neuropathies requires high‐throughput drug screening assays with appropriate cell types. Currently, immortalized dorsal root ganglion (DRG) sensory neuronal cell lines that maintain nociceptive sensory neuronal properties are not available. We generated immortalized DRG neuronal lines from embryonic day 14.5 rats. Here, we show that one of the immortalized DRG neuronal lines, 50B11, has the properties of a nociceptive neuron. When differentiated in the presence of forskolin, these cells extend long neurites, express neuronal markers, and generate action potentials. They express receptors and markers of small‐diameter sensory neurons and upregulate appropriate receptor populations when grown in the presence of glial cell line–derived neurotrophic factor or nerve growth factor. Furthermore, they express capsaicin receptor transient receptor potential vanilloid family‐1 (TRPV‐1) and respond to capsaicin with increases in intracellular calcium. In a 96‐well plate format, these neurons show a decline in ATP levels when exposed to dideoxycytosine (ddC) in a proper time‐ and dose‐dependent manner. This ddC‐induced reduction in ATP levels correlates with axonal degeneration. The immortalized DRG neuronal cell line 50B11 can be used for high‐throughput drug screening for neuroprotective agents for axonal degeneration and antinociceptive drugs that block TRPV‐1.
Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients

Gayatri Shankar Chilambi,Hayley R. Nordstrom,Daniel R. Evans,Jose A. Ferrolino,Randall T. Hayden,Gabriela M. Marón,Anh N. Vo,Michael S. Gilmore,Joshua Wolf,Jason W. Rosch,Daria Van Tyne

DOI: https://doi.org/10.1073/pnas.1917130117

IF: 11.1

2020-05-11

Proceedings of the National Academy of Sciences

Abstract:Significance Immunocompromised patients are at increased risk for multidrug-resistant infections, due to broad-spectrum antibiotic exposure and a host environment with limited innate defenses. This study explored how vancomycin-resistant Enterococcus faecium (VREfm), a pathogen endemic to many hospitals, underwent genomic and phenotypic changes during intestinal colonization and bloodstream infection of immunocompromised pediatric patients. We identified a mutation conferring bacterial growth in alternative sugars that arose de novo in two different patients and was also present in five other patients. We also characterized mutations in surface polysaccharide production associated with better adherence to surfaces and resistance to the innate immune factor lysozyme. These findings suggest that targeting carbohydrate availability and bacterial adherence may be worthwhile strategies to limit VREfm proliferation in immunocompromised hosts.
The Colonization of Vancomycin-Resistant Enterococcus (VRE): Prevalence, Molecular Epidemiology, and Risk Factors in Patients Admitted to Intensive Care Units in Beijing.

Mengyao Yan,Yuanhui He,Genjie Ruan,Feng Xue,Bo Zheng,Yuan Lv

DOI: https://doi.org/10.21203/rs.3.rs-880097/v1

2021-01-01

Abstract:Abstract Background: Vancomycin-resistant Enterococcus (VRE), as an important nosocomial pathogens, can be carried in gut for a long period and its colonization status associated with the subsequent infections. The aim of this study was to investigate the frequency of intestinal VRE colonization and identify the risk factors associated with VRE carriage in intensive care patients.Methods: We conducted a 4-week cross-sectional study at six hospitals in Beijing, China. Patients admitted to Intensive Care Units (ICUs) were screened for intestinal colonization of VRE every Tuesday morning. Rectal swabs were selectively cultured for VRE, then the identified strains were analyzed by PCR to detect the glycopeptide resistance gene and were characterized by MLST. Risk factors were recorded to assess their effect on VRE acquisition during ICUs stay.Results: Of 148 patients recruited, 46 (31.1%) were colonized with VRE, with the majority (n=42) being Enterococcus faecium. In total, 78.3% of the VRE were vanA positive and 15.2% vanM positive, while 6.5% undetected glycopeptide resistance gene. The predominant ST was ST78 (47.6%) followed by ST192 (14.3%), ST555 (9.5%), ST789 (9.5%), ST547 (4.8%), and ST922 (4.8%). Risk factors associated with VRE carriage were age of >65 years, a longer length of ICU stay, use of an endotracheal tube, and prior glycopeptides use.Conclusions: The overall incidence proportion of VRE colonization at ICUs was relatively high in Beijing, and clonal expansion and horizontal transmission of resistant genes were both found here. Routine screening is necessary to prevent the dissemination of VRE.
Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist

Wasim S El Nekidy,Maher M El-Masri,Islam M Ghazi,Derrick Soong

DOI: https://doi.org/10.1111/hdi.12775

Abstract:Background: Vancomycin is the default antibiotic to treat methicillin-resistant Staphylococcus aureus (MRSA) in hemodialysis (HD) units. Current guidelines recommend a vancomycin trough range of 15 to 20 mg/L for serious infections. Data regarding the clinical success of these recommendations are scarce in HD patients. Purpose: The purpose of this studies is to evaluate the treatment outcomes of vancomycin in HD patients. Methods: A retrospective chart review of HD outpatients who received parenteral vancomycin for suspected or documented MRSA infections in a community hospital in southwestern Ontario, Canada. Stepwise binary logistic regression analysis was conducted to identify the independent predictors of the treatment outcomes. Results: Of 77 HD patients, 113 vancomycin treatment courses were identified. The unadjusted bivariate comparisons suggested that there was no difference between treatment success and failure groups in terms of: mean loading dose (1663.6 ± 451.9 mg vs. 1614.3 ± 471 mg, P = 0.621), mean pre-HD concentration after loading dose (12.78 ± 4.4 mg/L vs. 13.34 ± 4.5 mg/L, P = 0.601), and mean maintenance dose (1012.1 ± 108 mg vs. 1069.7 ± 227 mg, P = 0.093). The groups were, however, different on their mean pre-HD drug concentration after maintenance dose (15.99 ± 4.6 mg/L vs. 19.9 ± 5.8 mg/L, P = 0.002). The adjusted logistic regression results, however, suggested that the type of infection was the only independent predictor of vancomycin success (OR = 11.07; 95% confidence interval [CI] = 3.2-38.48). Specifically, patients treated for bacteremia were 11 times more likely to experience cure as compared with diabetic foot infection and/or osteomyelitis. Similarly, those with skin and soft tissue infections were 10.7 times more likely to experience cure than those with diabetic foot infection and/or osteomyelitis (OR = 10.7; 95% CI = 3.63-31.58). Conclusion: The suggested vancomycin pre-HD concentration in the guidelines did not predict the treatment outcomes. Patients with bacteremia and/or skin or soft tissue infections were more likely to achieve clinical cure than patients with diabetic foot/osteomyelitis infections.
Genome analysis of multidrug resistant Enterococcus faecium and Enterococcus faecalis circulating among hospitalized patients in uMgungundlovu District, KwaZulu-Natal, South Africa

Raspail Carrel Founou,Luria Leslie Founou,Mushal Allam,Arshad Ismail,Sabiha Yusuf Essack

DOI: https://doi.org/10.1186/s12879-024-09380-3

2024-07-04

Abstract:Background: Vancomycin-resistant enterococci (VRE) are important pathogens categorized as high-priority bacteria in the Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics published by the World Health Organization. The aim of this study was to determine the risk factors, resistance, virulence, mobilomes associated with multidrug-resistant and clonal lineages of Enterococcus faecium and faecalis circulating among hospitalized patients following the health system in South Africa, using whole genome sequencing (WGS). Methods: A cross-sectional study was conducted during a two-month periods among hospitalized patients in 2017. Rectal swabs were collected from patients admitted to medical and surgical wards in an urban tertiary hospital, and a rural district hospital in uMgungundlovu district, South Africa. Enterococci were screened for vancomycin resistance on bile esculin azide agar supplemented with 6 mg/L of vancomycin and confirmation of VRE was done using ROSCO kits. Conventional and real-time PCR methods were used to ascertain the presence of VanA, VanB, VanC-2/3 and VanC-1 genes. All six multidrug-resistant Enterococcus faecalis and faecium selected were identified using multiplexed paired-end libraries (2 × 300 bp) with the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, USA) and genome sequencing was done using Illumina MiSeq instrument with 100× coverage at the National Institute of Communicable Diseases Sequencing Core Facility, South Africa. Antibiotic resistance genes, virulence factors, plasmids, integrons and CRISPR were characterized using RAST, ResFinder, VirulenceFinder, PlasmidFinder, PHAST and ISFinder respectively. Results: Sequencing analysis revealed that these strains harbouring numerous resistance genes to glycopeptides (vanC[100%], vex3[100%], vex2[83,33%] and vanG[16,66%]), macrolides, lincosamides, sterptogramine B (ermB[33,32%], Isa[16,66%], emeA[16,66%]) and tetracyclines (tetM[33,32%]) in both district and tertiary hospitals. Multidrug efflux pumps including MATE, MFS and pmrA conferring resistance to several classes of antibiotics were also identified. The main transposable elements observed were in the Tn3 family, specifically Tn1546. Four single sequence types (STs) were identified among E. faecium in the district hospital, namely ST822, ST636, ST97 along with a novel ST assigned ST1386, while one lineage, ST29 was detected in the tertiary hospital. Conclusion: The study reveals the genetic diversity and high pathogenicity of multidrug-resistant Enterococcus faecalis and faecium circulating among hospitalized patients. It underlines the necessity to implement routine screening of admitted patients coupled with infection control procedures, antimicrobial stewardship and awareness should be strengthened to prevent and/or contain the carriage and spread of multidrug resistant E. faecium and E. faecalis in hospitals and communities in South Africa.

Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung.

Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study

Multicenter Clinical Investigation of Vancomycin-resistant Enterococcus Infection

A Rare Case of Bacterial Meningitis Caused by Hematogenous Spread of Vancomycin-Resistant Enterococcus faecium in an Immunocompromised Patient

576. A Multicenter Epidemiology Study on Risk Factors of Vancomycin-Resistant Enterococcus Infections in China: Results from the China Antimicrobial Surveillance Network (CHINET) in 2016

Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

Exploring the design of an intentional naming scheme with an automatic constraint analyzer

Characterization of Clinical Enterococci Isolates, Focusing on the Vancomycin-Resistant Enterococci in a Tertiary Hospital in China: Based on the Data from 2013 to 2018

Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients

Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium

Prevalence, Microbial Etiology and Risk Factors Associated With Healthcare Associated Infections Among End Stage Renal Disease Patients on Renal Replacement Therapy

The evaluation of vancomycin-resistant enterococci and carbapenamase producing Klebsiella colonization among ICU-Hospitalized Patients

Intraperitoneal vancomycin treatment of multifocal methicillin-resistant Staphylococcus aureus osteomyelitis in a patient on peritoneal dialysis

Prevalence and Resistance Profiles of Pediatric Enterococcal Isolates: A Five-Year Update from Children's Medical Center Hospital, Tehran

Infective Endocarditis in Patients with End-Stage Renal Disease on Dialysis: Epidemiology, Risk Factors, Diagnostic Challenges, and Management Approaches

A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China

Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line

Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients

The Colonization of Vancomycin-Resistant Enterococcus (VRE): Prevalence, Molecular Epidemiology, and Risk Factors in Patients Admitted to Intensive Care Units in Beijing.

Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist

Genome analysis of multidrug resistant Enterococcus faecium and Enterococcus faecalis circulating among hospitalized patients in uMgungundlovu District, KwaZulu-Natal, South Africa